ICG plc (I2X2) Q2 2027 Earnings Report

The call was strongly constructive, supported by 18% FRE growth, 12% management fee growth, record fundraising, substantial cash generation, declining net debt and continued organic expansion across multiple strategies. Management also highlighted disciplined deployment and a strong balance sheet. However, the company is operating amid difficult macroeconomic and political conditions, muted buyout activity, uneven deployment, valuation uncertainty and below-target performance fee income. The highlights significantly outweighed the lowlights.

Management costs are guided within the medium-term “5% to 10% range,” with further hiring expected to be selective and targeted and additional technology investments expected to be “nothing that dramatically changes the cost envelope.” ICG’s medium-term target is “0 net financial debt,” and on a reasonable set of assumptions, “2027” could be the period when it reaches that target capital structure; excess capital is expected to be returned to shareholders, “likely to include a buyback in due course.” The company expects its second CLO risk retention fund to reach “north of $100 million” with scope to go larger, reducing balance-sheet capital required to support new CLOs by “about 80%” over time, expects its 4-year fundraising target “a year early,” plans to launch further funds “over the next 12 months,” and expects Strategic Equity VI’s first close “sometime during ’27.” Performance fees remain about “12%” of the mix over the last 5 years, within the “medium-term range,” with a run rate of “about the mid GBP 20 million area” in both H1 and H2.